Skip to content
sugarisadrug.com
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

Month: June 2026

1280-OR: Association between Preprocedural Glycemia and Adverse Cardiovascular Outcomes following Endovascular Revascularization in Diabetic Patients with Lower Extremity Arteriosclerosis Obliterans

June 9, 2026 by sugaradmin

Introduction and Objective: The association between preprocedural glycemia and major adverse cardiovascular events (MACEs) and major adverse limb events (MALEs) after endovascular revascularization in diabetic patients with lower extremity arteriosclerosis obliterans (LEASO) remains unclear. The aim of this study is to explore the link between preprocedural glycaemic control and the 1-year risk of MACEs and […]

Read More
DiabetesLeave a Comment on 1280-OR: Association between Preprocedural Glycemia and Adverse Cardiovascular Outcomes following Endovascular Revascularization in Diabetic Patients with Lower Extremity Arteriosclerosis Obliterans

1267-OR: Ademaglitazone Improves Whole-Body Insulin Sensitivity while Limiting Adipogenesis and Promoting Neuroprotection in Diet-Induced Diabesity

June 9, 2026 by sugaradmin

Introduction and Objective: “Diabesity,” the coexistence of obesity and type 2 diabetes, is a major global health problem characterized by systemic insulin resistance (IR) and increased risk of neurodegenerative complications. Although thiazolidinedione (TZD) PPAR-γ agonists improve insulin sensitivity, their clinical use is limited by adverse effects including adipogenesis, weight gain, and cardiovascular risk. We developed […]

Read More
DiabetesLeave a Comment on 1267-OR: Ademaglitazone Improves Whole-Body Insulin Sensitivity while Limiting Adipogenesis and Promoting Neuroprotection in Diet-Induced Diabesity

1231-OR: Glucocorticoid Receptor Is Vital for Maternal β-Cell Compensation to Protect against Gestational Diabetes

June 9, 2026 by sugaradmin

Introduction and Objective: Gestational β-cell compensation is an adaptive mechanism by which maternal islets increase insulin secretion to overcome pregnancy-induced insulin resistance. Defective β-cell compensation leads to gestational diabetes mellitus (GDM). We characterized the role of glucocorticoid receptor (GR) in gestational β-cell compensation.Methods: We generated β-cell GR-knockout (βGR-KO) mice, followed by determining the abilities of […]

Read More
DiabetesLeave a Comment on 1231-OR: Glucocorticoid Receptor Is Vital for Maternal β-Cell Compensation to Protect against Gestational Diabetes

1266-OR: Tirzepatide and Pioglitazone Combination Therapy Synergistically Improves Insulin Sensitivity and Adipose Tissue Remodeling

June 9, 2026 by sugaradmin

Introduction and Objective: Tirzepatide, a dual GLP-1 and GIP receptor agonist, enhances glucose-stimulated insulin secretion, significantly reduces HbA1c, and promotes weight loss. Tirzepatide use leads to improvements in insulin sensitivity, both via weight loss-dependent and independent mechanisms. Pioglitazone, a PPARγ activator, enhances insulin sensitivity via distinct pathways. We hypothesized that combining Tirzepatide and pioglitazone would […]

Read More
DiabetesLeave a Comment on 1266-OR: Tirzepatide and Pioglitazone Combination Therapy Synergistically Improves Insulin Sensitivity and Adipose Tissue Remodeling

1247-OR: Evolocumab Reduces CV Events in Patients with High-Risk Diabetes: Results from the VESALIUS-CV Trial

June 8, 2026 by sugaradmin

Introduction and Objective: PCSK9 inhibition with evolocumab (evo) decreased CV events in pts at high CV risk w/o a prior MI or stroke in VESALIUS-CV. This pre-specified analysis evaluates the efficacy of evo in pts w/ high-risk diabetes mellitus (HR-DM) for prevention of first CV events.Methods: VESALIUS-CV randomized pts w/ LDL-C ≥90mg/dL and atherosclerosis or […]

Read More
DiabetesLeave a Comment on 1247-OR: Evolocumab Reduces CV Events in Patients with High-Risk Diabetes: Results from the VESALIUS-CV Trial

1251-OR: Sustained Effect of a Teaching Kitchen Program for Type 2 Diabetes in Japan: Results from a Randomized Controlled Trial

June 8, 2026 by sugaradmin

Introduction and Objective: To address the unmet need for sustainable lifestyle interventions in type 2 diabetes (T2D), we evaluated the sustained effects of a Teaching Kitchen (TK) program among patients with T2D in Japan.Methods: We conducted a randomized controlled trial with 112 patients (59 men, 53 women) aged 20-79 years with T2D and BMI ≥23 […]

Read More
DiabetesLeave a Comment on 1251-OR: Sustained Effect of a Teaching Kitchen Program for Type 2 Diabetes in Japan: Results from a Randomized Controlled Trial

1232-OR: Dynamic CGM Models to Predict GDM: A GO MOMs Analysis

June 8, 2026 by sugaradmin

Introduction and Objective: In GO MOMS, a multicenter observational study, % time above range (TAR) >134mg/dL, as determined from early pregnancy CGM, added statistically significant but not clinically meaningful predictive value for GDM compared to clinical factors alone. We sought to assess if prediction models incorporating CGM metrics derived from multiple time points improved GDM […]

Read More
DiabetesLeave a Comment on 1232-OR: Dynamic CGM Models to Predict GDM: A GO MOMs Analysis

1243-OR: Novel Montelukast Derivatives for Treating Diabetic Retinopathy

June 8, 2026 by sugaradmin

Introduction and Objective: Early-stage diabetic retinopathy (DR) is characterized by vascular endothelial cell damage and breakdown of the blood-retinal barrier. We and others previously shown that CysLTR1 antagonist Montelukast (MON) is a promising treatment for diabetes-related eye issues. This study aims to develop and assess the effectiveness of new MON derivatives in alleviating endothelial dysfunction […]

Read More
DiabetesLeave a Comment on 1243-OR: Novel Montelukast Derivatives for Treating Diabetic Retinopathy

1239-OR: Treatment with Oxamate Improves the Counterregulatory Responses to Hypoglycemia in Diabetic Rats

June 8, 2026 by sugaradmin

Introduction and Objective: Despite advances in the development of new insulin formulations and the use of diabetes technologies, severe hypoglycemia remains a major problem for people with type 1 diabetes on intensive insulin therapy due in part to defective counterregulatory hormone responses and a lack of symptomatic awareness of hypoglycemia. Elevated brain lactate levels in […]

Read More
DiabetesLeave a Comment on 1239-OR: Treatment with Oxamate Improves the Counterregulatory Responses to Hypoglycemia in Diabetic Rats

1268-OR: Multiplexed In Vivo Screening of Visceral Adipocytes Reveals Multiple Manifestations of Insulin Sensitivity and a Novel Target to Treat Obesity

June 8, 2026 by sugaradmin

Introduction and Objective: To achieve adipose mass reduction while maintaining or improving insulin sensitivity involves an integration of multiple neuroendocrine and paracrine inputs that requires an in vivo setting to be adequately studied. We therefore performed in vivo Perturb-Seq of visceral adipocytes to identify novel targets for the treatment of obesity.Methods: An AAV library encoding […]

Read More
DiabetesLeave a Comment on 1268-OR: Multiplexed In Vivo Screening of Visceral Adipocytes Reveals Multiple Manifestations of Insulin Sensitivity and a Novel Target to Treat Obesity

Posts navigation

Older posts
Newer posts

Recent Posts

  • Sex-Dependent Diabetes Impact of Acute Grp78 Deletion in β-Cells of Adult Mice
  • Activating Transcription Factor 6α Governs Stress-Adaptive Pancreatic β-Cell Mass Expansion by Coordinating Proliferation and Survival
  • Co-occurrence of Loss-of-Function GCK and ABCC8 Variants in a Pedigree With a Spectrum of Dysglycemia
  • Whey Protein Ingestion Stimulates Glucagon Secretion and Raises Blood Glucose Levels in Adults With Type 1 Diabetes
  • Islet Autotransplant Recipients Have Elevated Proinsulin–to–C-Peptide Ratios Supporting Metabolic Stress as a Cause of Islet Attrition

Recent Comments

  • A WordPress Commenter on SUCROSE: “PURE” ENERGY AT A PRICE

Archives

  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • November 2024
  • October 2024
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • May 2017

Categories

  • Celebrity Health
  • Diabetes
  • Food Choices
  • Fructose
  • General Sugar
  • Glucose
  • Health News
  • Insulin
  • Mental Health
  • Natural Unrefined Sugar
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Sucrose
  • Sugar Science

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

© 2026 Sugar is a DRUG | Sugar Addiction Awareness